Yoshihiko Shimokawa - Concepedia

Author

Yoshihiko Shimokawa

Otsuka (Japan)

Also Known As

Y. Shimokawa, Yoshihiko Shimokawa

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Otsuka (Japan)The University of Tokyo National Institute of Health Sciences Otsuka Pharmaceutical (Spain)Japan Science and Technology Agency

About

Yoshihiko Shimokawa is an author at Otsuka (Japan) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	392
2	Natural Sciences	5	5	170
3	Engineering	3	3	84
4	Education	1	1	25
5	Allergy	1	1	14

Yoshihiko Shimokawa

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice Makoto Matsumoto, Hiroyuki Hashizume, Tatsuo Tomishige, PLoS Medicine	2006	735
Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products Nahoko Uchiyama, Yoshihiko Shimokawa, Maiko Kawamura, Forensic Toxicology Cannabis UseCathinone DerivativesPsychoactive DrugChemical AnalysisDrug Design	2014	107
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Drug Metabolism and Disposition	2015	89
Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products Nahoko Uchiyama, Satoru Matsuda, Maiko Kawamura, Forensic Science International Pharmaceutical ResearchIllegal ProductsDrug DesignMedicineRational Drug Design	2014	74
High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinetic study Yoshihiko Shimokawa, Hitoshi Akiyama, Eiji Kashiyama, Journal of Chromatography B Pharmacological StudyMedicinePharmacokinetic StudyAnalytical ChemistryPharmacotherapy	2005	74
Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products Nahoko Uchiyama, Yoshihiko Shimokawa, Satoru Matsuda, Forensic Toxicology Cannabis UseMedicinal ChemistryIllegal ProductsPsychoactive DrugPharmacology	2013	58
A structure-based mechanism for benzalacetone synthase from <i>Rheum palmatum</i> Hiroyuki Morita, Yoshihiko Shimokawa, Michikazu Tanio, Proceedings of the National Academy of Sciences	2009	49
Benzophenone synthase from Garcinia mangostana L. pericarps Natsajee Nualkaew, Hiroyuki Morita, Yoshihiko Shimokawa, Phytochemistry Medicinal ChemistryBiosynthesisBioorganic ChemistryNatural SciencesNatural Product Biosynthesis	2012	48
A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura‐Hanajiri, Forensic Toxicology	2015	45
Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Drug Metabolism and Disposition	2015	45

Page 1